Alignment Healthcare, Inc.
NASDAQ:ALHCMedical - Healthcare Plans
+$0.48 today
- Market cap
- $1.41B
- Beta
- 1.15
- P/E (TTM)
- 227.0
- EPS (TTM)
- $0.10
Volume 6.79M
Average 5.33M
ALHC Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Alignment Healthcare, Inc.NASDAQ: ALHC
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures declines year over year
Q1 FY2026 capital expenditures of $7.36M (cash outflow) fell 10.8% year over year, ahead of the -60.1% change in trailing-twelve-month capital expenditures. Sequentially, it fell 54.7% from the prior quarter. Over 3 fiscal years it compounded at +4.0% a year.
Context
- Capital expenditures amounted to 0.7% of revenue in FY2025, down 0.9 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -10.8% holds above the trailing-twelve-month pace of -60.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (26.78M) USD
- Year-over-year change
- +35.3%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (26.78M) | +35.3% |
| FY2024 | 2024-12-31 | (41.42M) | -15.1% |
| FY2023 | 2023-12-31 | (36M) | -51.4% |
| FY2022 | 2022-12-31 | (23.77M) | -29.5% |
| FY2021 | 2021-12-31 | (18.36M) | — |
Capital Expenditures vs competitors
How ALHC compares with its peers on the latest reported figures
- ALHC's LTM Mar 2026 capital expenditures of $15.37M is the smallest of the 7 companies compared; the peer median is $695M.
- Its year-over-year change of -60.1% is the lowest of 7, against a peer median of +6.3%.
- Capital expenditures amounts to 0.4% of revenue for ALHC, versus a peer median of 0.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.37B | -6.1% | +8.9% | 0.7% | |
| LTM Sep 2026 | $1.08B | -5.5% | -1.1% | 0.5% | |
| LTM Jun 2026 | $798M | +22.8% | -8.6% | 0.4% | |
| LTM Sep 2026 | $592M | +18.9% | -21.7% | 0.4% | |
| LTM Sep 2026 | $93M | -17.7% | +3.5% | 0.2% | |
| LTM Jun 2026 | $38.63M | +18.2% | +7.8% | 0.3% | |
| LTM Mar 2026 | $15.37M | -60.1% | +4.0% | 0.4% | |
| Peer median (excluding ALHC) | $695M | +6.3% | +1.2% | 0.4% | |
Competitors are the stored peer set for ALHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (195.29M) | (149.64M) | (148.17M) | (128.07M) | (724K) |
| Depreciation & Amortization | 16.03M | 17.49M | 21.67M | 27.06M | 31.61M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 110.6M | 81.72M | 66.84M | 71.13M | 62.08M |
| Change in Working Capital | (19.42M) | (5.55M) | 2.03M | 60.89M | 35.14M |
| Accounts Receivables | (17.61M) | (34.38M) | (26.95M) | (34.28M) | (100.11M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 437K | 13.74M | (6.35M) | (1.46M) | 0 |
| Other Working Capital | (2.25M) | 15.08M | 35.32M | 96.63M | 135.25M |
| Other Non-Cash Items | 9.29M | 10.56M | (1.54M) | 3.76M | 11.82M |
| Operating Cash Flow | (78.78M) | (45.43M) | (59.19M) | 34.77M | 139.93M |
| Capital Expenditures | (18.36M) | (23.77M) | (36M) | (41.42M) | (26.78M) |
| Acquisitions (Net) | 0 | (4.04M) | 0 | 0 | 1.14M |
| Purchases of Investments | (2.48M) | (2.83M) | (379.06M) | (82.2M) | (65.63M) |
| Sales of Investments | 1.43M | 2.43M | 267.79M | 162.8M | 76.3M |
| Other Investing Activities | (1.41M) | 0 | 0 | 14K | 0 |
| Investing Cash Flow | (20.82M) | (28.22M) | (147.26M) | 39.19M | (14.97M) |
| Debt Repayment | 0 | 21.82M | 0 | 165M | 0 |
| Common Stock Issued | 390.6M | 0 | 0 | 0 | 18.07M |
| Common Stock Repurchased | (1.47M) | 0 | 0 | (350K) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (29M) | (5.23M) | 105K | (8.62M) | (26K) |
| Financing Cash Flow | 360.13M | 16.59M | 105K | 156.03M | 18.04M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 260.54M | (57.05M) | (206.35M) | 229.99M | 142.99M |
| Free Cash Flow | (97.14M) | (69.2M) | (95.18M) | (6.65M) | 113.15M |
Alignment Healthcare, Inc.
NASDAQ:ALHC
Intrinsic Alpha fair value
Locked
Current Price
$6.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.